Emmy Award-winning television journalist and sportscaster Bryant Gumbel was named this year's recipient of the NFL Players Association Georgetown Lombardi Award.
Colon Cancer Alliance has changed its name to Colorectal Cancer Alliance. The name change is part of a larger rebranding effort for the organization which includes a new logo and visual identity, new website, and commitment to accuracy for the entire colorectal cancer community. With the strategic mission of servicing both colon and rectal cancer... […]
The Trump administration should consider NIH and the biomedical research enterprise as a component of the nation's “defense” when making budgetary decisions, said Rep. Tom Cole (R-OK), chairman of the House Appropriations Subcommittee for Labor-HHS, Education, and Related Agencies.
With a month to go before his Dec. 1 start date as president of MD Anderson Cancer Center, Peter Pisters reflected on the challenges that await him in Houston.
Genentech announced FDA has accepted the company's supplemental Biologics License Application for Avastin (bevacizumab) in combination with chemotherapy (carboplatin and paclitaxel), followed by Avastin alone, for the front-line treatment of advanced ovarian cancer.
Immune Design said the European Medicines Agency has granted Orphan Drug Designation for G100 for the treatment of follicular non-Hodgkin's lymphoma. G100 has also been granted orphan drug designation by the FDA for the treatment of follicular non-Hodgkin's lymphoma.
The National Coalition for Cancer Survivorship presented its second annual Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care.
Stand Up To Cancer, joined by the Lustgarten Foundation for Pancreatic Cancer Research, LUNGevity, and the American Lung Association, announced four teams of researchers who will focus on on cancers of the lung and pancreas using the new approach of “interception” of cancers at very early stages.
Stand Up To Cancer has awarded 10 SU2C Catalyst clinical trial projects in which researchers from more than 30 institutions collaborate across academic and corporate borders on clinical trials across a variety of cancers, in a program supported by industry.
Barbara McAneny received the Annual Achievement Award of the Association of Community Cancer Centers.
